enVVeno Medical Corporation (NASDAQ: NVNO)
$2.8200
-0.0900 ( -3.09% ) 101.7K
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Market Data
Open
$2.8200
Previous close
$2.9100
Volume
101.7K
Market cap
$49.98M
Day range
$2.8120 - $2.9350
52 week range
$2.4500 - $6.9700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 23, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 20, 2024 |
4 | Insider transactions | 1 | Dec 19, 2024 |
def | Proxies and info statements | 7 | Nov 19, 2024 |